The AGEs-RAGE axis and nonalcoholic steatohepatitis: the evidence mounts.
Yilmaz
Yusuf
Y
D000924:Anticholesteremic Agents / Q000494:pharmacology; D000069059:Atorvastatin; D015415:Biomarkers / Q000097:blood; D005234:Fatty Liver / Q000188:drug therapy / Q000503:physiopathology*; D017127:Glycation End Products, Advanced / Q000097:blood*; D006538:Heptanoic Acids / Q000494:pharmacology; D006801:Humans; D011758:Pyrroles / Q000494:pharmacology; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic / Q000378:metabolism*
D000924:Anticholesteremic Agents; D015415:Biomarkers; D017127:Glycation End Products, Advanced; D006538:Heptanoic Acids; D011758:Pyrroles; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic; D000069059:Atorvastatin
Atherosclerosis. 2010 Mar;209(1):173-7
19733353
Trends Cardiovasc Med. 2002 Aug;12(6):258-62
12242049
Am J Physiol Gastrointest Liver Physiol. 2008 May;294(5):G1281-7
18388185
Curr Vasc Pharmacol. 2010 Jan;8(1):86-92
19485931
Free Radic Biol Med. 2007 Nov 1;43(9):1231-2
17893035
Free Radic Biol Med. 2007 Nov 1;43(9):1255-62
17893038
Curr Mol Med. 2007 Dec;7(8):743-51
18331232
Adv Drug Deliv Rev. 2002 Dec 7;54(12):1615-25
12453678
J Gastroenterol. 2010 Jul;45(7):750-7
20112031